The incumbent will serve as a Clinical Leader in Neurodegeneration, focusing on innovative late-phase drug development for Alzheimer's Disease projects.
Base: $226,000 to $391,000 USD; Bonus/Equity: Long-term incentive program available; Benefits: Medical, dental, vision, 401(k), paid time off
Must-have
Nice-to-have
Not specified